L
L. Venerandi
Researcher at University of Bologna
Publications - 20
Citations - 743
L. Venerandi is an academic researcher from University of Bologna. The author has contributed to research in topics: Hepatocellular carcinoma & Sorafenib. The author has an hindex of 10, co-authored 20 publications receiving 630 citations.
Papers
More filters
Journal ArticleDOI
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
Francesca Fornari,Manuela Ferracin,Davide Treré,Maddalena Milazzo,Sara Marinelli,M. Galassi,L. Venerandi,Daniela Pollutri,Clarissa Patrizi,Alberto Borghi,Francesco Giuseppe Foschi,Giuseppe Francesco Stefanini,Massimo Negrini,Luigi Bolondi,Laura Gramantieri +14 more
TL;DR: It is shown that circulating microRNAs deserve attention as non-invasive biomarkers in the diagnostic setting of HCC and that exosomal secretion contributes to discharging a subset of micro RNAs into the extracellular compartment.
Journal ArticleDOI
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study
Mario Scartozzi,Luca Faloppi,Gianluca Svegliati Baroni,Cristian Loretelli,Fabio Piscaglia,Massimo Iavarone,Pierluigi Toniutto,Giammarco Fava,Samuele De Minicis,Alessandra Mandolesi,Maristella Bianconi,Riccardo Giampieri,Alessandro Granito,Floriana Facchetti,Davide Bitetto,Sara Marinelli,L. Venerandi,Sara Vavassori,S. Gemini,Antonietta D'Errico,Massimo Colombo,Luigi Bolondi,Italo Bearzi,Antonio Benedetti,Stefano Cascinu +24 more
TL;DR: Once prospectively validated, the analysis of VEGF and VEGFR SNPs may represent a clinical tool to better identify HCC patients more likely to benefit from sorafenib.
Journal ArticleDOI
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
Massimo Iavarone,Fabio Piscaglia,Sara Vavassori,M. Galassi,Angelo Sangiovanni,L. Venerandi,Laura Forzenigo,Rita Golfieri,Luigi Bolondi,Massimo Colombo +9 more
TL;DR: ICC in cirrhotic patients displays distinct vascular patterns at CT-scan that allow for differentiation from HCC, and all nodules lacked the radiological hallmark of HCC.
Journal ArticleDOI
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound
M. Galassi,Massimo Iavarone,Sandro Rossi,Simona Bota,Sara Vavassori,Laura Conde de la Rosa,Simona Leoni,L. Venerandi,Sara Marinelli,Angelo Sangiovanni,Letizia Veronese,Mirella Fraquelli,Alessandro Granito,Rita Golfieri,Massimo Colombo,Luigi Bolondi,Fabio Piscaglia +16 more
TL;DR: This study validated the percentage of intrahepatic cholangiocarcinomas which have a contrast vascular pattern at contrast enhanced ultrasound (CEUS) at risk of misdiagnosis with hepatocellular carcinoma (HCC) and verified if any characteristics in the CEUS pattern helps to identify ICC.
Journal ArticleDOI
The role of ultrasound elastographic techniques in chronic liver disease: Current status and future perspectives
Fabio Piscaglia,Sara Marinelli,Simona Bota,Carla Serra,L. Venerandi,Simona Leoni,Veronica Salvatore +6 more
TL;DR: Liver ultrasound elastography allows the non-invasive evaluation of liver stiffness, providing information regarding the stage of fibrosis, comparable to liver biopsy which is still considered the gold standard; in this way, it can help physicians in managing patients, including the decision as to when to start antiviral treatment.